Joint Core Is successfully validated by clinical studies.
Read More
Joint Core® contains (Natural Egg Shell Membrane (Muttai Jow Complex®) 400 mg, AKBACORE® Boswellia serrata (30%AKBA) 90 mg and CUMINCORE ® (Curcumin extract 96%) 10 mg) thereof, as branded bio-actives based formulation that exhibits improvements on as anti-inflammatory, cartilage regeneration and reduction of tiredness are published in the Clinical studies CTRI/2021/08/035335
What is the Specialty of Joint Core®
Joint Core® is made by exclusive and advanced Nano- Nano Binding Technology developed by Microcore Pvt Ltd.
Jointcore® is a novel synergistic formula for comprehensive management of arthritis. It offers three ingredients
MUTTAIJOW COMPLEX ®
AKBACORE®
CUMINCORE®
it acts via different pathways to offer symptomatic relief; reducing pain, inflammation and joint stiffness and increasing mobility. NESM® works as biogenic precursor to fix the body damage of collagen, cartilage and synovial fluids. NESM® also fixes the faults in the immune system to reduce cartilage destruction and helps in joint lubrication, reduces synovial effusion and synovial inflammation and increases muscle strength, AKBACORE® prevents formation of inflammatory mediators to reduce pain and inflammation and also prevents cartilage destruction by by HLE and CO inhibition and CUMINCORE® helps on multiple aspects and as CO inhibition.
To study the efficacy of Joint Core® (Natural egg shell membrane) (Muttai Jow Complex ® ) 400 mg + ABKACORE® Boswellia serrata (30%AKBA) 90 mg + CUMINCORE® (Curcumin extract 96%) 10 mg) compared to Jointace DN (Glucosamine 750 mg + Diacerein 50 mg + msm 250 mg) in osteoarthritis patients.
To assess the safety and tolerability of Joint Core ® (Natural egg shell membrane (Muttai Jow Complex ® ) ) 400 mg + ABKACORE ® Boswellia serrata (30%AKBA) 90 mg + CUMINCORE ® (Curcumin extract 96%) 10 mg) by monitoring the occurrence of any adverse effects by clinical and laboratory evaluation.
Participants were then randomized into two groups
with 25 in each group.
Arm 1: Participants with osteoarthritis knee - one
tablet of Joint Core thrice daily orally for 12
weeks
Arm 2: Participants with osteoarthritis knee - one
tablet of Jointace DN twice daily orally for 12
weeks
Change from baseline to 12 weeks in knee pain intensity measured by Pain VAS Scale(0-100 mm)
Change From Baseline to 12 Weeks in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale.
Changes from base line to 12
weeks in following laboratory parameter(s):
*Hs-C Reactive Protein*ESR*Fibrinogen
Change in Baseline to 12 Weeks in Patient's Global Assessment of Osteoarthritis.
Number of Participants With a Response Rate Measured by the Outcome Measures for Rheumatology Committee and Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative (OMERACT-OARSI).
Changes from base line to 12
weeks in Quality of life- Questionnaires (Short
Form Health-12 ).
1. A randomized, open‑label, multicentered parallel‑group clinical study to evaluate the efficacy and safety of Joint Core TM compared to Jointace DN TM in osteoarthritis patients 2022 Journal of Current Research in Scientific Medicine | Published by Wolters Kluwer Medknow jcrsm_21_22_R2_OA 10.4103/jcrsm.jcrsm_21_22
1. A randomized, open‑label, multicentered parallel‑group clinical study to evaluate the efficacy and safety of Joint Core TM (Natural Eggshell Membrane [MuttaiJow Complex TM] 400 mg + Akbacore TM Boswellia serrata [30% Akba] 90 mg + Cumincore TM [curcumin extract 96%] 10 mg) compared to Jointace DN TM (glucosamine 750 mg + diacerein 50 mg + methylsulfonylmethane 250 mg) in osteoarthritis patients 2022 Journal of Current Research in Scientific Medicine | Published by Wolters Kluwer Medknow jcrsm_21_22_R2_OA 10.4103/jcrsm.jcrsm_21_22
Pain management is much better and early with Joint Core® as per the comparative data on PAIN VAS SCALE, WOMAC PAIN SUB SCALE, GLOBAL ASSESMENT ON IMPROVEMENTS ON OSTEO ARTHRITIS SCORE, OMERACT-OARSI. Thus Nutraceuticals Combinations of Joint Core® has proved to be equivalent to that of the reference Drug combinations of Jointace DN in the management of Osteoarthritis patients by reducing inflammation, providing adequate pain relief and improving the patients functional capacity, without causing any major side effects or drug interactions as it is obtained from natural sources.
Joint Core® reduce Sr creatinine values by 25 % from 1.1 (+/- ) 1.0 at zero day to 0.83 (+/-) 0.19 in 12 weeks.
Joint Core® has Anti-inflammatory activity to CONTROL the HS- CRP inflammatory markers from o day at 7.15 (+/- ) 4.6 to 3.86 (+/- ) 2.91 in 12 weeks
Joint Core® has Anti-inflammatory activity to CONTROL the ESR inflammatory markers from o day at 45.75 (+/- ) 32.83 to 9.0 (+/- ) 4.5 in 12 weeks
Joint Core® has Inflammatory markers: Fibrinogen Levels from 0 day at 309.29 (+/- ) 96.31 to 9.0 (+/- ) 4.5 in 12 weeks.
Joint Core®
has shown significant improvement in
Osteoarthritis patients with respect to the management
of pain, reduction of inflammatory markers and
functional
improvement.
Joint Core® , has proved to be a good natural supplement for taking care of Joint pain, joint stiffness and thereby improving the joint flexibility and mobility in Osteoarthritis patients.The Test product, Joint Core® (Natural egg shell membrane (Muttai Jow Complex® ) 400 mg + ABKACORE® Boswellia serrata (30%AKBA) 90 mg + CUMINCORE® (Curcumin extract96%) 10 mg) has shown significant improvement in Osteoarthritic patients with respect to the management of pain, reduction of inflammatory markers and functional improvement.
Thus, the test product Joint Core® has proved to be equivalent to that of the reference product Jointace DN in the management of Osteoarthritis patients by reducing inflammation, providing adequate pain relief and improving the patients functional capacity, without causing any major side effects or drug interactions as it is obtained from natural sources. Thus, Joint Core® , has proved to be a good natural supplement for taking care of Joint pain, joint stiffness and thereby improving the joint flexibility and mobility in Osteoarthritic patients.
The first line pharmacological
therapy for Osteoarthritis consists of topical or oral
non-steroidal anti-inflammatory drugs (NSAIDS) which
only provide symptomatic pain relief and it is
associated with serious life time risk after prolonged
use. However continuous usage of NSAIDs can increase the
chance of heart attack or stroke with higher doses or
with long-term use. It is very uncertain that the
patients are not aware about the fundamental difference
between the effects on short term prescribed drugs vs.
the long term prescribed drugs. Such lack of awareness
makes OA patients dependent on the unethical practice or
self practice of drugs and makes their life miserable
over the period of time with severe damages on Liver and
Kidney.
Changes in knee pain intensity measured by Pain VAS Scale (0-100 mm).
Change in the Western Ontario and McMaster Universities (WOMAC) Pain Subscale
Change in the Physical Function Subscale
BHs C Reactive Protein, ESR
Change in Patients Global Assessment of Osteoarthritis.
Changes in the WOMAC Stiffness Subscale
Microcore develops and manufactures nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies. Microcore has evolved, since its inception in 2007 from a research company to a fully-integrated, innovation-led, emerging global Nutraceuticals enterprise committed to reduce therapy costs of chronic conditions like Arthritis, Osteoarthritis and Inflammatory diseases. The company has enjoyed accelerated growth, generating impressive sales worldwide, by launching a diverse portfolio of innovative products.
The visionary was founded by M. Chandra Mohan an Entrepreneurial Scientist with the aim to discover and develop highly innovative, potent Nutraceuticals and intelligent food supplements to support healthy life.
He firmly believed the conceptualization of "MADE IN INDIA" hence single handily made the enablement. R&D infrastructure, Process development and Production facility is located in Erode (15,000 sqm ) & Karur (12 Acres), Textile and Turmeric City of South India. Our in house R&D is RECOGNIZED by DEPARTMENT OF SCIENTIFIC AND INDUSTRIAL RESEARCH (DSIR) - GVT OF INDIA.
Our cumulative experiences over 20 years in research, operation and manufacturing has catalyst scientific and industrial research with key focus on developing sustainable technologies, primarily dealing with innovative and highly potent Nutraceutical, Medical foods to treat Arthritis and Osteoporosis.
Jointcore® is a novel synergistic formula for comprehensive management of arthritis. It offers three ingredients (Natural Egg Shell Membrane (NESM)® , AKBACORE® AKKBA (Acetyl-11-keto-beta-boswellic acid (30% AKKBA) and CUMINCORE®. AKBACORE® act via different pathways to offer symptomatic relief; reducing pain, inflammation and joint stiffness and increasing mobility. NESM works as biogenic precursor to fix the body damage of collagen, cartilage and synovial fluids. NESM also fixes the faults in the immune system to reduce cartilage destruction and helps in joint lubrication, reduces synovial effusion and synovial inflammation and increases muscle strength, Boswellin Super prevents formation of inflammatory mediators to reduce pain and inflammation and also prevents cartilage destruction.
MUTTAIJOW COMPLEX®
|
AKBACORE®
* CO Inhibitor
|
CUMINCORE®
* LO Inhibitor
|
Muttaijow Complex ® (NESM) is a Natural way of improving your health by adding novel dietary supplement processed from crude Egg Shell Membrane by unique and highly innovative separation technologies, the product is free from insecticides, pesticides and chemical residues. It contains egg membrane, shell calcium carbonate (bio-calcium), naturally occurring Collagen Type-1,V,X Elastin, Chondroitin Sulfate , Glycosaminoglycans, Membranous protein, Hyaluronic acid etc and other fractional molecules that includes, Growth factor β, Ovocalixin, Ovocleidin, Ovotransferrin, Desmosine, Isodesmosine and Sulphur-bearing amino acids as essential to maintaining healthy joint and connective tissues. AKBACORE® and CUMINCORE® helps safe pain management.
Shri M.Chandra Mohan is an Entrepreneurial Scientist, fundamentally a Microbiologist & Bio-Process engineer. He has over 20 years of experience in research, operation, production and management of Biotech industries.
He is a visionary to bring highly innovative health care products in to Domestic market with international standards and incorporated Microcore Research Laboratories India Pvt Limited in the year 2007. His previous experiences includes Associate Scientific Manager at Biocon Biopharmaceuticals Ltd, Bangalore, India.
His expertise includes secondary metabolites, echinocandin, polyketides, (Small molecules generics), high value enzyme fermentations, API fermentation, Biological, Cell Culture Fermentation, egg process, natural egg shell membrane collagen, Chicken sternum collagen type-2, modified starch, dietary fiber research and manufacturing.
Backed by two decades of experiences in R&D, Formulation, Operation and Scale up.
Microcore Research Labs India was Incorporated as Pvt Ltd company with the aim to conduct exclusive Research to develop innovative nutraceutical molecules.
Research arms were driven for developing nutraceutical molecules for Arthritis, Osteo-Arthritis, dietary fibers for colon-rectal cancer, advanced probiotics for hyper cholestremia, natural wound healing molecules, calcite and immune boosters from fermented and fractional food molecules.
Registered several patents for the production of Natural Egg Shell Membrane, Collagen, Elastin, Calcium, Calcite.
Developed several process technologies and molecules for medicinal purpose that has significant impact on healthy aging.
Successfully established commercial activities backed by complete regulatory compliances.
Signed Exclusive Supply agreement with Akums Drugs and Pharmaceuticals for NESM® and the patent for the production of NESM® got granted.
Received Health claim from FSSAI DELHI for NESM® for maintaining healthy joints and connective tissues and instrumental to establish 12 brands in Indian market.
Successfully completed Clinical studies for Joint core.
Microcore step in to the formulation and marketing business.
Patent granted for the production of Undenatured Chicken Sternum Collagen Complex.
Jointcore® is not a Drug or API or NCE it is a food supplement made from Egg and Phyto extract approved by FSSAI DELHI.it is clinically validated, It's is 100% Safe 100% Result and 100% Made in India.It has nano bound combinations of Natural Egg Shell Membrane, Boswellia Serrate extract and Curcumin. It is a natural way of improving your health by adding novel dietary supplement processed from crude Egg Shell Membrane. It is free from insecticides, pesticides and chemical residues. It contains egg membrane, shell calcium carbonate (bio-calcium), naturally occurring Collagen Type-1,V,X Elastin, Chondroitin Sulfate , Glycosaminoglycans, Membranous protein, Hyaluronic acid etc and other fractional molecules that includes, Growth factor β, Ovocalixin, Ovocleidin, Ovotransferrin, Desmosine, Isodesmosine and Sulphur-bearing amino acids as essential to maintaining healthy joint and connective tissues.
Jointcore® helps in multiple way
Jointcore the most accepted brand with known facts on safety.
Joint Core Is successfully validated by clinical studies.
Read More01 July 2022
The detail of the studies are published in the Journal of Orthopedics
Read More
02 February 2023
Grand launch at Coimbatore & Chennai.
Read MorePl contact for Distribution and Marketing requirements
Registered Office| Corporate Office | R&D & Unit-1Microcore Research Labs India Pvt Ltd 9th km, 204-A Palani Main Road, Checkumedu, Erode - 638115 (Dt) Tamil Nadu,India. www.microcoreresearch.com +91 9659003519
|
Unit-2 - Factory Factory No 355 & 356, 20 KM from Trichy, Alathur , Via Trichy to Thogamalai,
Karur- 621313 (Dt), Tamil Nadu, India. www.microcoreresearch.com +91 9659003519 |